OLSI News

Origin Life Sciences, which is developing a high-energy plasma medical device for dermal and wound care, revised the terms for its upcoming IPO on Monday. In its latest filing, the company also disclosed financials for the three months ended March 31, 2023. The Princeton, NJ-based company now plans to raise $15 million by offering 3 million shares at $5. The company had previously...read more

Two small issuers began trading this past week, one of which is eligible for inclusion in our IPO stats, joined by one blank check IPO. Three small IPOs and one SPAC submitted initial filings. Though there were no large launches or pricings, three issuers on file to raise $100+ million disclosed updated financials: Chinese pet hospital company New Ruipeng Pet Group...read more

Origin Life Sciences, which is developing a high-energy plasma medical device for dermal and wound care, filed on Monday with the SEC to raise up to $15 million in an initial public offering. The Princeton, NJ-based company plans to raise $15 million by offering 3 million shares at a price range of $4 to $6. At the midpoint of the proposed range, Origin Life Sciences would command...read more